Bayesian statistics and the efficiency and ethics of clinical trials
From MaRDI portal
Publication:1766323
DOI10.1214/088342304000000044zbMath1057.62096OpenAlexW2006656814MaRDI QIDQ1766323
Publication date: 7 March 2005
Published in: Statistical Science (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1214/088342304000000044
adaptive designsclinical trialsdecision analysisBayesian updatingpredictive probabilitiesauxiliary endpointsclinical ethicsextreme analysis
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Bayesian problems; characterization of Bayes procedures (62C10)
Related Items (16)
Approximating the operating characteristics of Bayesian uncertainty directed trial designs ⋮ An induced natural selection heuristic for finding optimal Bayesian experimental designs ⋮ The gamma beta ratio distribution ⋮ Response-adaptive randomization in clinical trials: from myths to practical considerations ⋮ A new response-adaptive design for continuous treatment responses for phase III clinical trials ⋮ Optimal and lead-in adaptive allocation for binary outcomes: A comparison of Bayesian methods ⋮ Simple Bayesian Algorithms for Best-Arm Identification ⋮ Bayesian Experimental Design for Models with Intractable Likelihoods ⋮ Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design ⋮ Computational advances for and from Bayesian analysis ⋮ Incorporating Bayesian ideas into health-care evaluation ⋮ Sequential Methods in Multi-Arm Clinical Trials ⋮ A Parallel Phase I/II Clinical Trial Design for Combination Therapies ⋮ Accounting for Variability in Sample Size Estimation with Applications to Nonadherence and Estimation of Variance and Effect Size ⋮ Randomized phase III oncology trials: a survey and empirical Bayes inference ⋮ On the efficient determination of optimal Bayesian experimental designs using ABC: a case study in optimal observation of epidemics
Cites Work
This page was built for publication: Bayesian statistics and the efficiency and ethics of clinical trials